Immunoglobulin supplementation is a debated strategy in fighting sepsis. We evaluated a polyclonal IgM and IgA enriched immunoglobulin (IgMeIVIG) preparation in reducing the short term mortality in extremely low birth weight neonates (ELBW) with proven infection
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...
Introduction: Newborn children conceived before 32 weeks of incubation are genuinely immune deficien...
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...
Immunoglobulin supplementation is a debated strategy in fighting sepsis. We evaluated a polyclonal I...
Aim: To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-...
As a result of inadequate placental transport of maternal IgG, preterm neonates of <32 weeks &apo...
Despite critical care advances, robust antibiotic therapy and improved strategies in early detection...
PubMedID: 10832472A total of 76 premature newborn infants with gestational age of 34 weeks or less w...
Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...
Background Neonatal sepsis is a major cause of death and complications despite antibiotic treatment....
To determine whether there was an association between adjunctive therapy with IgM-enriched immunoglo...
Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impa...
The influence of IgM-enriched immunoglobulin therapy on neonatal mortality and hematological variabl...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
Infection is a leading cause of mortality and morbidity in the newborn and preterm neonates due to i...
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...
Introduction: Newborn children conceived before 32 weeks of incubation are genuinely immune deficien...
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...
Immunoglobulin supplementation is a debated strategy in fighting sepsis. We evaluated a polyclonal I...
Aim: To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-...
As a result of inadequate placental transport of maternal IgG, preterm neonates of <32 weeks &apo...
Despite critical care advances, robust antibiotic therapy and improved strategies in early detection...
PubMedID: 10832472A total of 76 premature newborn infants with gestational age of 34 weeks or less w...
Aim: Additional treatments for sepsis to be administered alongside the standard therapy recommended ...
Background Neonatal sepsis is a major cause of death and complications despite antibiotic treatment....
To determine whether there was an association between adjunctive therapy with IgM-enriched immunoglo...
Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impa...
The influence of IgM-enriched immunoglobulin therapy on neonatal mortality and hematological variabl...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
Infection is a leading cause of mortality and morbidity in the newborn and preterm neonates due to i...
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...
Introduction: Newborn children conceived before 32 weeks of incubation are genuinely immune deficien...
Introduction In patients with septic shock, low levels of circulating immunoglobulins are common and...